Medicines containing the active ingredient tirzepatide
GLP-1RAs GLP-1RAs include different molecules, derived by the modification of either native human GLP-1 (liraglutide, semaglutide, dulaglutide, and albiglutide) or exendin-4 GLP-1 peptides (exenatide and lixisenatide), with different administration frequency (daily or weekly), administration route (oral or subcutaneous injection), and delivery (single or multidose or capsule) [26]
You want education, reminders, motivation, and support that helps keep the plan alive between coaching check-ins
The therapeutic efficacy of GLP-1RAs is underscored by their ability to significantly lower glycated hemoglobin (HbA1c) levels, with reductions ranging from 0.42% to 1.6% depending on the formulation and duration of treatment
That creates uncertainty for patients who may begin treatments that many experts view as lifelong therapies
She currently serves as a bariatric dietitian with Wellstar